Ingmar Gorman, PhD and Co-Founder of Fluence
Lucia Huang, MBA, Co-Founder and CEO of Osmind
September 23rd, 3:00 PM PDT (Pacific Daylight Time/Los Angeles)
Fluence has contributed to the field of Psychedelic Harm Reduction and Integration through its training and the recent publishing of a foundational therapeutic model. In pursuit of an evidenced-based approach to Psychedelic Integration, we are launching a research study to learn more about therapists and their clients. This research is made possible with the support of Osmind. Their electronic health record software will be used to survey participants in the study.
The primary aim of this prospective observational study is to obtain basic information about therapists who provide psychedelic integration, to better understand clients who seek psychedelic integration from these therapists, and whether such patients report improvements in wellbeing and decreases in stigma associated with seeking care. If you choose to participate in this study as a therapist, you will be asked to complete a single brief survey about your practice. With Osmind, therapists will then be able to enroll their clients in the study and easily send a survey after each psychotherapy session.
If you are interested in contributing to this research, we would like you to attend our webinar taking place Wednesday, September 15th at 9 AM Pacific and Thursday, September 23rd at 3 PM Pacific. There, we will provide greater detail about the methods of the research, as well as orient you to the survey software. To attend, please click "Register" and fill out the proposed form which will be used as a webinar invitation. If you have any questions you can email us at email@example.com
At this time you must be located in the USA to qualify for this research study.